Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Eur J Med Res ; 27(1): 251, 2022 Nov 15.
Article in English | MEDLINE | ID: covidwho-2115714

ABSTRACT

BACKGROUND: Patients with non-alcoholic fatty liver disease (NAFLD) may be more susceptible to coronavirus disease 2019 (COVID-19) and even more likely to suffer from severe COVID-19. Whether there is a common molecular pathological basis for COVID-19 and NAFLD remains to be identified. The present study aimed to elucidate the transcriptional alterations shared by COVID-19 and NAFLD and to identify potential compounds targeting both diseases. METHODS: Differentially expressed genes (DEGs) for COVID-19 and NAFLD were extracted from the GSE147507 and GSE89632 datasets, and common DEGs were identified using the Venn diagram. Subsequently, we constructed a protein-protein interaction (PPI) network based on the common DEGs and extracted hub genes. Then, we performed gene ontology (GO) and pathway analysis of common DEGs. In addition, transcription factors (TFs) and miRNAs regulatory networks were constructed, and drug candidates were identified. RESULTS: We identified a total of 62 common DEGs for COVID-19 and NAFLD. The 10 hub genes extracted based on the PPI network were IL6, IL1B, PTGS2, JUN, FOS, ATF3, SOCS3, CSF3, NFKB2, and HBEGF. In addition, we also constructed TFs-DEGs, miRNAs-DEGs, and protein-drug interaction networks, demonstrating the complex regulatory relationships of common DEGs. CONCLUSION: We successfully extracted 10 hub genes that could be used as novel therapeutic targets for COVID-19 and NAFLD. In addition, based on common DEGs, we propose some potential drugs that may benefit patients with COVID-19 and NAFLD.


Subject(s)
COVID-19 , MicroRNAs , Non-alcoholic Fatty Liver Disease , Humans , Non-alcoholic Fatty Liver Disease/genetics , Non-alcoholic Fatty Liver Disease/metabolism , Gene Regulatory Networks , Systems Biology , Gene Expression Profiling , Computational Biology , COVID-19/genetics , MicroRNAs/genetics
2.
Data science and engineering ; : 1-26, 2022.
Article in English | EuropePMC | ID: covidwho-1898349

ABSTRACT

Complex networks have been used widely to model a large number of relationships. The outbreak of COVID-19 has had a huge impact on various complex networks in the real world, for example global trade networks, air transport networks, and even social networks, known as racial equality issues caused by the spread of the epidemic. Link prediction plays an important role in complex network analysis in that it can find missing links or predict the links which will arise in the future in the network by analyzing the existing network structures. Therefore, it is extremely important to study the link prediction problem on complex networks. There are a variety of techniques for link prediction based on the topology of the network and the properties of entities. In this work, a new taxonomy is proposed to divide the link prediction methods into five categories and a comprehensive overview of these methods is provided. The network embedding-based methods, especially graph neural network-based methods, which have attracted increasing attention in recent years, have been creatively investigated as well. Moreover, we analyze thirty-six datasets and divide them into seven types of networks according to their topological features shown in real networks and perform comprehensive experiments on these networks. We further analyze the results of experiments in detail, aiming to discover the most suitable approach for each kind of network.

3.
Front Med (Lausanne) ; 8: 566609, 2021.
Article in English | MEDLINE | ID: covidwho-1699160

ABSTRACT

OBJECT: To evaluate the clinical efficacy and safety of α-Lipoic acid (ALA) for critically ill patients with coronavirus disease 2019 (COVID-19). METHODS: A randomized, single-blind, group sequential, active-controlled trial was performed at JinYinTan Hospital, Wuhan, China. Between February 2020 and March 2020, 17 patients with critically ill COVID-19 were enrolled in our study. Eligible patients were randomly assigned in a 1:1 ratio to receive either ALA (1200 mg/d, intravenous infusion) once daily plus standard care or standard care plus equal volume saline infusion (placebo) for 7 days. All patients were monitored within the 7 days therapy and followed up to day 30 after therapy. The primary outcome of this study was the Sequential Organ Failure Estimate (SOFA) score, and the secondary outcome was the all-cause mortality within 30 days. RESULT: Nine patients were randomized to placebo group and 8 patients were randomized to ALA group. SOFA score was similar at baseline, increased from 4.3 to 6.0 in the placebo group and increased from 3.8 to 4.0 in the ALA group (P = 0.36) after 7 days. The 30-day all-cause mortality tended to be lower in the ALA group (3/8, 37.5%) compared to that in the placebo group (7/9, 77.8%, P = 0.09). CONCLUSION: In our study, ALA use is associated with lower SOFA score increase and lower 30-day all-cause mortality as compared with the placebo group. Although the mortality rate was two-folds higher in placebo group than in ALA group, only borderline statistical difference was evidenced due to the limited patient number. Future studies with larger patient cohort are warranted to validate the role of ALA in critically ill patients with COVID-19. CLINICAL TRIAL REGISTRATION: http://www.chictr.org.cn/showproj.aspx?proj=49534.

4.
medrxiv; 2021.
Preprint in English | medRxiv | ID: ppzbmed-10.1101.2021.06.15.21259004

ABSTRACT

Objective To mine Reddit to discover long-COVID symptoms self-reported by users, compare symptom distributions across studies, and create a symptom lexicon. Materials and Methods We retrieved posts from the /r/covidlonghaulers subreddit and extracted symptoms via approximate matching using an expanded meta-lexicon. We mapped the extracted symptoms to standard concept IDs, compared their distributions with those reported in recent literature and analyzed their distributions over time. Results From 42,995 posts by 4249 users, we identified 1744 users who expressed at least 1 symptom. The most frequently reported long-COVID symptoms were mental health-related symptoms (55.2%), fatigue (51.2%), general ache/pain (48.4%), brain fog/confusion (32.8%) and dyspnea (28.9%) amongst users reporting at least 1 symptom. Comparison with recent literature revealed a large variance in reported symptoms across studies. Temporal analysis showed several persistent symptoms up to 15 months after infection. Conclusion The spectrum of symptoms identified from Reddit may provide early insights about long-COVID.


Subject(s)
Dyspnea , Fatigue , Pain , Confusion
SELECTION OF CITATIONS
SEARCH DETAIL